• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid

cafead

Administrator
Staff member
  • cafead   Apr 09, 2018 at 10:02: AM
via The article discusses the concern over the number of deaths (244) and other adverse events linked to nuplazid. The drug was approved in April of 2016 as a much needed treatment for Parkinson's disease psychosis.

article source